Corporate development and M&A advisory for global management teams, boards, and investors

Medtech venture capital and private equity

Led global organization responsible for strategic planning, portfolio management, business & corporate development, ventures, and integrations; reported to Chairman & CEO, member of executive operating committee. Spearheaded enterprise-wide strategic evaluation and portfolio redesign to enhance operational effectiveness, accelerate innovation, and drive shareholder value creation, rotating Baxter into larger, higher growth markets, executing over $8B in complex carve-out divestitures to private equity

acquired by LeanTaaS

Led Medtronic’s push into personalized spine surgery. Developed transformational digital strategy, acquired and integrated public company, stood up operating unit and scaled to market leadership through accelerated commercial, operational, and R&D execution. Exceeded financial expectations every quarter; co-located in Lyon, France and New York, NY

Led extensive portfolio management activities to catalyze growth for $5B Cranial & Spinal Technologies division. Acquisitions, divestitures, and partnerships including Mazor Robotics, Titan Spine, and Medicrea acquisitions

Led M&A for ~$8B business group; multiple transactions across various geographies, including numerous acquisitions, JVs, and ~$6B Covidien medical supplies business divestiture

Covidien acquisition integration team

Strategic sales, pricing & contracts, and business development for leading national health systems

M&A and strategic investments across medtech

2018 IPO

Value-based care partnerships with leading health systems and payors

acquired by Teleflex

acquired by Covidien / Medtronic

M&A and public market financing advisory across healthcare